Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy
Fierce Pharma
Thu, 01/16/25 - 11:08 am
Tags:
Gilead Sciences, DOJ, HHS, patents, Truvada, Descovy, legal
Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma
Fierce Biotech
Mon, 01/13/25 - 11:03 am
Tags:
Gilead Sciences, JPMHC 2025, LEO Pharma, inflammation
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
BioSpace
Thu, 12/19/24 - 11:27 am
Tags:
Gilead Sciences, Assembly Bio, funding, hepatitis D
ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases
Fierce Pharma
Thu, 12/12/24 - 11:44 pm
Tags:
ICER, drug pricing, Gilead Sciences, JNJ, Novartis
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Fierce Pharma
Wed, 12/11/24 - 11:40 am
Tags:
Gilead Sciences, Biktarvy, patent cliffs, HIV
Can CAR-T first movers keep pace in a rapidly evolving market?
Pharmaphorum
Wed, 12/11/24 - 10:59 am
Tags:
CAR-T, Gilead Sciences, Novartis
Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti
BioSpace
Tue, 12/10/24 - 11:41 am
Tags:
Gilead Sciences, Arcellx, anito-cel, JNJ, Carvykti, Multiple Myeloma
Gilead looks beyond Trodelvy with Tubulis alliance
Pharmaphorum
Tue, 12/3/24 - 09:41 am
Tags:
Gilead Sciences, Tubulis, antibody-drug conjugates
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Clinical Trials Arena
Sun, 12/1/24 - 11:46 am
Tags:
Gilead Sciences, clinical trials, lenacapavir, HIV, PrEP
Gilead’s Livdelzi shows promise in PBC clinical trial
Clinical Trials Arena
Mon, 11/18/24 - 11:08 am
Tags:
Gilead Sciences, Livdelzi, primary biliary cholangitis, clinical trials
Gilead lays off 72 workers in Seattle, plans to shutter R&D support site
Fierce Biotech
Thu, 11/14/24 - 11:08 pm
Tags:
Gilead Sciences, Seattle, R&D, layoffs
Autolus enters CAR-T race with FDA approval for Aucatzyl
Fierce Pharma
Mon, 11/11/24 - 11:49 am
Tags:
Autolus Therapeutics, CAR-T, FDA, Aucatzyl, Gilead Sciences, Novartis, relapsed or refractory B-cell precursor acute lymphoblastic leukemia
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Fierce Pharma
Thu, 11/7/24 - 11:29 am
Tags:
Gilead Sciences, earnings, Trodelvy, CAR-T
Gilead, Merck say HIV combo could be weekly, oral HIV drug
Pharmaphorum
Mon, 10/21/24 - 09:35 am
Tags:
Gilead Sciences, Merck, HIV, antiretrovirals, clinical trials, islatravir, Sunleca
Gilead withdraws bladder cancer drug in US after failed trial
Reuters
Fri, 10/18/24 - 11:35 am
Tags:
Gilead Sciences, Trodelvy, bladder cancer, clinical trials
With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude
Fierce Pharma
Thu, 10/17/24 - 09:23 am
Tags:
GSK, Gilead Sciences, PrEP, HIV, Apretude
Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
Fierce Biotech
Fri, 10/11/24 - 11:14 am
Tags:
Gilead Sciences, Yuhan, MASH
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Reuters
Wed, 10/2/24 - 09:55 pm
Tags:
Gilead Sciences, generics, HIV, lenacapavir
Gilead's Kite exits China cell therapy joint venture with Fosun Pharma
Fierce Pharma
Thu, 09/19/24 - 09:22 pm
Tags:
Gilead Sciences, Kite Pharma, China, Fosun Kite Biotechnology, Fosun Pharma
Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’
BioPharma Dive
Mon, 09/16/24 - 10:14 pm
Tags:
Kyverna Therapeutics, Gilead Sciences, Kite Pharma, CAR-T, cell therapy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.